Cassava Sciences Inc (SAVA)
20.49
+0.85
(+4.33%)
USD |
NASDAQ |
Apr 22, 16:00
20.45
-0.04
(-0.20%)
Pre-Market: 09:11
Cassava Sciences Cash from Financing (TTM): 2.56M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 2.56M |
September 30, 2023 | 48.76M |
June 30, 2023 | 48.43M |
March 31, 2023 | 47.66M |
December 31, 2022 | 47.80M |
September 30, 2022 | 0.466M |
June 30, 2022 | 0.405M |
March 31, 2022 | 1.56M |
December 31, 2021 | 192.34M |
September 30, 2021 | 262.95M |
June 30, 2021 | 263.86M |
March 31, 2021 | 262.83M |
December 31, 2020 | 75.45M |
September 30, 2020 | 10.71M |
June 30, 2020 | 9.715M |
March 31, 2020 | 9.479M |
December 31, 2019 | 5.806M |
September 30, 2019 | -0.132M |
June 30, 2019 | 12.14M |
March 31, 2019 | 12.14M |
December 31, 2018 | 14.10M |
September 30, 2018 | 14.17M |
June 30, 2018 | 1.898M |
March 31, 2018 | 1.898M |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | -0.024M |
June 30, 2017 | -0.024M |
March 31, 2017 | -0.238M |
December 31, 2016 | -0.284M |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | 0.379M |
September 30, 2014 | 0.643M |
June 30, 2014 | 0.643M |
March 31, 2014 | 0.584M |
December 31, 2013 | 0.524M |
September 30, 2013 | -34.17M |
June 30, 2013 | -34.17M |
March 31, 2013 | -34.23M |
December 31, 2012 | -34.24M |
September 30, 2012 | -0.073M |
June 30, 2012 | -0.021M |
March 31, 2012 | 4.278M |
December 31, 2011 | 8.703M |
September 30, 2011 | -75.87M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.132M
Minimum
Sep 2019
263.86M
Maximum
Jun 2021
68.57M
Average
12.14M
Median
Jun 2019
Cash from Financing (TTM) Benchmarks
Amylyx Pharmaceuticals Inc | 3.543M |
MannKind Corp | 136.61M |
Clearside Biomedical Inc | 0.414M |
Lantern Pharma Inc | -0.50M |
NovaBay Pharmaceuticals Inc | 1.91M |